Beijing Suncadia Pharmaceuticals Co., Ltd

This study tested whether adding a new injectable drug called SHR-1918 to standard cholesterol pills could help patients who still have high 'bad' cholesterol (LDL-C) despite taking their regular medication. It involved 335 adults with poorly controlled cholesterol levels. Resear…

This study tested whether a new drug called SHR-1918 could lower bad cholesterol in people with a rare, severe genetic condition called homozygous familial hypercholesterolemia. Fifty-five participants received either the drug or a placebo for 24 weeks while continuing their usua…

This study tested an experimental drug called SHR-1918 in 26 patients with a rare, inherited form of very high cholesterol. The goal was to see if the drug could safely lower their 'bad' LDL cholesterol levels over 12 weeks. All participants received the drug while continuing the…

This study tested whether a new injectable drug called SHR-1918 could safely lower cholesterol in people whose levels were not well controlled. Forty-four adults received either the drug or a placebo injection over 24 weeks to see how much it reduced their 'bad' LDL cholesterol. …